Moolec Science (MLEC) Gross Margin (2023 - 2024)
Moolec Science's (MLEC) quarterly Gross Margin came in at 25.52% in Q4 2024, down 11757.0% year-on-year from N/an in Q1 2024, and down 2789.22% quarter-over-quarter from 0.95% in Q3 2024.
Moolec Science (MLEC) Gross Margin (2023 - 2024) Analysis & Trends
Moolec Science has disclosed Gross Margin across 2 years of filings, most recently posting 25.52% for Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 79.04% |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 86.85% |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -25.52% |
| Sep 30, 2024 | 0.95% |
| Mar 31, 2024 | 4.35% |
| Dec 31, 2023 | 92.05% |
| Sep 30, 2023 | 12.67% |